IP Library Patent Application 13583441
Patent Application
App. No. 13/583,441

LACTIC ACID BACTERIUM-CONTAINING PREPARATION

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/583,441
Abstract

The present invention provides very safe lactic acid bacteria and lactic acid bacteria preparations which are effective in prevention and therapy of allergies and/or in lowering of the blood neutral fat level. The present invention also provides pharmaceutical products and food or drink products which contain, as an active ingredient, a composition that contains cultured cells of the lactic acid bacterium Pediococcus acidilactici R037 or a treated product thereof.

Claims (14)

1 . A lactic acid bacterium, which is a strain of Pediococcus acidilactici R037 (accession number NITE BP-900) or a variant of the strain R037 having at least one of an antiallergic function, a neutral fat-lowering function, and an anti-autoimmune disease function.

2 . A composition which comprises cultured cells of the lactic acid bacterium according to claim 1 or a treated product thereof.

3 . An antiallergic agent comprising the composition according to claim 2 .

4 . A neutral fat-lowering agent comprising the composition according to claim 2 .

5 . An anti-autoimmune disease agent comprising the composition according to claim 2 .

6 . The agent according to claim 3 , which is a pharmaceutical product or an animal drug.

7 . A food or drink product comprising the composition according to claim 2 .

8 . The food or drink product according to claim 7 , which has at least one of an antiallergic function, a blood neutral fat-lowering function, and an anti-autoimmune disease function.

9 . The food or drink product according to claim 7 , which is a functional food or a dietary supplement.

10 . A method for treating at least one of an allergic disease, hypertriglyceridemia, and an autoimmune disease,

the method comprising administering the composition according to claim 2 to a subject.

11 . The agent according claim 4 which is a pharmaceutical product or an animal drug.

12 . The agent according claim 5 which is a pharmaceutical product or an animal drug.

13 . The food or drink product according to claim 8 , which is a functional food or a dietary supplement.

Assignments (2)
CHANGE OF ADDRESS Recorded Sep 12, 2013
From: KANEKA CORPORATION
To: KANEKA CORPORATION
Reel/Frame 031207/0283 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2012
From: TATEGAKI, AIRO; WATANABE, TOYOAKI; HAMADA, KAZUYA
To: KANEKA CORPORATION
Reel/Frame 029313/0731 →